Abstract
T-cell large granular lymphocytic leukaemia (T-LGL) is a lymphoproliferative disease that presents with immune-mediated cytopenias and is characterised by clonal expansion of cytotoxic CD3+ CD8+ lymphocytes. Use of methotrexate, ciclosporin, or cyclophosphamide as first therapy improves cytopenias in 50% of patients, but long-term use of these can lead to toxicity. We aimed to explore the activity and safety of alemtuzumab, an anti-CD52 monoclonal antibody, in patients with T-LGL. We did this single-arm, phase 2 trial in consecutively enrolled adults with T-LGL referred to the National Institutes of Health in Bethesda, MD, USA. Alemtuzumab was given intravenously at 10 mg per day for 10 days. The primary endpoint was haematological response at 3 months after infusion. A complete response was defined as normalisation of all affected lineages, and a partial response was defined in neutropenic patients as 100% increase in the absolute neutrophil count to more than 5 × 10(8) cells per L, and in those with anaemia, as any increase in haemoglobin of 20 g/L or higher observed in at least two serial measurements 1 week apart and sustained for 1 month or longer without exogenous growth factors support or transfusions. Analysis was by in...Continue Reading
References
Apr 1, 1977·The American Journal of Medicine·R W McKennaR D Brunning
Jan 15, 1990·Cancer·F PandolfiF Salsano
Mar 1, 1989·Controlled Clinical Trials·R Simon
Jun 1, 1994·Leukemia & Lymphoma·T E WitzigA Tefferi
Feb 13, 2001·The Journal of Clinical Investigation·P K Epling-BurnetteT P Loughran
Sep 21, 2001·British Journal of Haematology·F WillisE C Gordon-Smith
Apr 15, 2003·The Hematology Journal : the Official Journal of the European Haematology Association·J Joseph MelenhorstA John Barrett
Oct 9, 2003·British Journal of Haematology·Xiuqing Ru, Howard A Liebman
Nov 18, 2003·British Journal of Haematology·Minoo BattiwallaA John Barrett
Feb 21, 2004·Blood·Michael D RosenblumDavid H Vesole
Apr 10, 2004·Blood·Daniel J LenihanMadeleine Duvic
Aug 23, 2005·Leukemia Research·Wing-Yan AuYok-Lam Kwong
Jun 24, 2006·Cancer·Nnenna OsujiDaniel Catovsky
Oct 19, 2006·Leukemia Research·Ahmed AribiFarhad Ravandi
Dec 7, 2006·Blood·Phillip ScheinbergA John Barrett
Jul 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephan StilgenbauerUNKNOWN German Chronic Lymphocytic Leukemia Study Group
Oct 2, 2009·Haematologica·Sanjay R MohanJaroslaw P Maciejewski
Mar 10, 2010·Leukemia Research·Hélène MonjanelDelphine Senecal
Apr 7, 2010·Leukemia & Lymphoma·Anne F FortuneElisabeth Vandenberghe
Nov 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elaine M SloandNeal S Young
Dec 31, 2010·Blood·Thierry Lamy, Thomas P Loughran
Sep 29, 2011·Blood·Claire E DeardenDaniel Catovsky
Nov 10, 2011·Blood·Phillip ScheinbergNeal S Young
Aug 4, 2012·Blood·Andres JerezJaroslaw P Maciejewski
Nov 6, 2012·Lancet·Alasdair J ColesUNKNOWN CARE-MS II investigators
Nov 6, 2012·Lancet·Jeffrey A CohenUNKNOWN CARE-MS I investigators
Apr 19, 2013·Blood·Hanna L M RajalaSatu Mustjoki
Citations
Jan 25, 2017·Blood·Thierry LamyThomas P Loughran
Jan 28, 2017·Expert Review of Hematology·Estella Matutes
Jul 22, 2019·Brain : a Journal of Neurology·Steven A GreenbergDavid M Dorfman
Jun 22, 2017·Leukemia & Lymphoma·Srinivasa R SanikommuJaroslaw P Maciejewski
Sep 21, 2018·American Society of Clinical Oncology Educational Book·Aline Moignet, Thierry Lamy
Mar 7, 2019·Nature Reviews. Rheumatology·Steven A Greenberg
Sep 15, 2017·British Journal of Haematology·Swapna ThotaJaroslaw P Maciejewski
Jun 11, 2020·British Journal of Haematology·Zachary BraunsteinJonathan E Brammer
Oct 6, 2019·Best Practice & Research. Clinical Haematology·Gregorio BarilàRenato Zambello
Mar 4, 2021·Blood·Carmelo Gurnari, Jaroslaw P Maciejewski
Apr 6, 2021·American Journal of Hematology·Ning DongLubomir Sokol
Aug 19, 2021·Best Practice & Research. Clinical Haematology·Bhavisha A PatelNeal S Young
Apr 30, 2020·Acta Haematologica·Christina PohJoseph Tuscano
Nov 24, 2021·British Journal of Haematology·Christopher P FoxGraham Collins